Lannett Company Inc represents values of integrity, commitment to quality, and ethical conduct in the pharmaceutical industry. The company's corporate philosophy revolves around providing affordable generic medications, ensuring patient safety, and delivering value to shareholders. Lannett Company Inc focuses on manufacturing high-quality generic pharmaceuticals, adhering to stringent regulatory standards, and leveraging its expertise to meet the evolving healthcare needs of patients. With a strong commitment to innovation, growth, and transparency, Lannett Company Inc strives to be a trusted partner for healthcare providers and a leader in the pharmaceutical industry.

Lannett Company Inc is primarily present in the United States.

Lannett Company Inc, a leading pharmaceutical company, has achieved significant milestones throughout its history. One notable achievement is the company's successful development and commercialization of a diverse range of generic pharmaceutical products. Lannett has consistently expanded its product portfolio, offering high-quality, affordable medications to customers. Additionally, the company has demonstrated notable financial growth, emphasizing its strong market position and commitment to sustainable success. Lannett's continuous focus on research and development, strategic partnerships, and regulatory compliance has contributed to its reputation as a trusted industry leader. Overall, Lannett Company Inc's achievements reflect its dedication to providing valuable healthcare solutions and driving sustainable growth in the pharmaceutical sector.

Lannett Company Inc, a leading pharmaceutical company based in the United States, has a rich history and background. Established in 1942, the company specializes in the development, manufacture, and distribution of generic pharmaceuticals. Lannett Company Inc has grown substantially over the years, leveraging its expertise to deliver affordable medicines that meet the diverse needs of patients worldwide. With a strong commitment to quality, innovation, and customer satisfaction, Lannett has become a trusted name in the pharmaceutical industry. The company's extensive product portfolio covers various therapeutic areas, contributing to its continued success and reputation as a reliable provider of high-quality generic medications.

Lannett Company Inc faces competition from several key players in the market. Some of its main competitors include Teva Pharmaceutical Industries Ltd, Mylan NV, Amneal Pharmaceuticals Inc, and Mallinckrodt Pharmaceuticals. These companies also operate in the generic pharmaceuticals industry, providing similar products and services to customers. Being a prominent player in the market, Lannett Company Inc continually strives to stay competitive by offering high-quality generic medications and maintaining strong relationships with customers and healthcare professionals.

Lannett Company Inc is primarily active in the pharmaceutical industry.

The business model of Lannett Company Inc, a pharmaceutical company based in the United States, focuses on the development, manufacture, marketing, and distribution of generic pharmaceutical products. Lannett specializes in producing high-quality medications that are affordable for patients, offering a wide range of products across various therapeutic areas. With a commitment to quality and customer satisfaction, Lannett collaborates with healthcare professionals and partners worldwide to provide cost-effective generic alternatives for patients. The company's business model revolves around delivering affordable and accessible healthcare solutions, aiming to improve patient outcomes while addressing the needs of the healthcare industry.

Az Lannett Company P/E mutatója -0,00.

Az Lannett Company KUV 0,00.

Az AlleAktien Minőségi Score Lannett Company esetében 3/10.

A várt Lannett Company forgalma 309,90 Mió. USD.

A(z) várt Lannett Company nyereség -236,43 Mió. USD.

Lannett Company Inc is a pharmaceutical company specializing in the development, manufacturing, and distribution of generic drugs. The company was founded in 1942 and is headquartered in Philadelphia, USA. The business model of Lannett Company Inc is based on offering generics of prescription drugs at a lower price than the original brand product. Lannett's products are approved by the US Food and Drug Administration (FDA) and meet the same safety and quality standards as the original medication. The company produces a wide range of generics, including medications for pain, infections, blood pressure problems, and heart diseases. Lannett's product range covers both domestic and international markets. The domestic markets include the USA and Canada, while the international markets are in Europe, Asia, and South America. The company offers its products through various distribution channels such as wholesalers, pharmacies, and hospitals. The company has three main business segments: generics, contract manufacturing, and pipeline products. In the generics segment, Lannett produces a wide range of generics of prescription drugs, providing a cost-effective alternative to branded products. The contract manufacturing segment involves the production of active ingredients and drugs for other companies. In the pipeline products segment, the company develops new products that are not yet on the market. Lannett has also made some partnerships and acquisitions to expand its business and broaden its product offering. In 2019, the company acquired the generics business of Kremers Urban Pharmaceuticals, strengthening its presence in the US market. Lannett's business model has proven to be successful due to a strong demand for generic drugs, which are preferred by consumers due to their lower costs. The company has also benefited from the aging population, as older people typically receive more prescribed medications, leading to higher demand for generics. Overall, Lannett Company Inc offers a wide range of generics at lower costs than the brand product, approved by the FDA and meeting the same safety and quality standards. The company has engaged in various business segments to expand its business and broaden its product offering, which has been successful.

A(z) Lannett Company évente alkalommal oszt ki 0 USD összegű osztalékot.

A Lannett Company esetében jelenleg nem lehet kiszámítani a osztalékot, vagy a vállalat nem fizet osztalékot.

A(z) Lannett Company ISIN kódja: US5160121019.

A Lannett Company WKN-je 882871.

Az Lannett Company tőzsdei rövidítése LCI.

Az elmúlt 12 hónapban a(z) Lannett Company osztalékot fizetett összegben. Ez körülbelül osztalékhozamnak felel meg. A következő 12 hóban a(z) Lannett Company várhatóan 0 USD összegű osztalékot fog fizetni.

A(z) Lannett Company jelenlegi osztalékhozama .

A(z) Lannett Company negyedévente fizet osztalékot. Az osztalékokat a következő hónapokban osztják ki: .

A Lannett Company az elmúlt 0 évben minden évben fizetett osztalékot.

A következő 12 hónapban 0 USD összegű osztalékra számítanak. Ez 0 % osztalékhozamnak felel meg.

A(z) Lannett Company a(z) 'Egészség' szektorhoz van besorolva.

Az utolsó, Lannett Company által 2024. 07. 13.-án/én fizetett 0 USD összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti 2024. 07. 13.-nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése 2024. 07. 13. időpontban történt.

2023 évben a Lannett Company 0 USD összegű osztalékot fizetett ki.

Az Lannett Company osztalékait USD fizeti ki.